Home            Past Issues            About IP            About IAP           Author Information            Subscription            Advertisement              Search  

   
research letter

Indian Pediatr 2014;51: 496-497

Dengue Associated Hemophagocytic Lymphohistiocytosis: A Case Series


Priyankar Pal, Prabhas Prasun Giri and *AV Ramanan

From Departments of Pediatric Rheumatology, Institute of Child Health, Kolkata, India and
*Bristol Royal Hospital for Children, UK.
Email: [email protected]
 

 


Hemophagocytic lymphohistiocytosis is a rare complication of dengue. We present 8 cases of dengue associated hemophagocytic lymphohistiocytosis diagnosed in our hospital during the dengue outbreak of 2012. All the cases were treated with a short (4 weeks) course of steroids along with supportive measures, and showed an excellent response.

Keywords: Dengue fever, Hepatomegaly, Splenomegaly.



Hemophagocytic lymphohistiocytosis (HLH) is a heterogeneous group of clinical syndromes characterised by activation and subsequent uncontrolled non-malignant proliferation of T-lymphocytes and macrophages, leading to a cytokine storm. The clinical features are: fever, hepatosplenomegaly, multiorgan dysfunction and fulminant pancytopenia resembling severe sepsis [1]. Persistence of fever for more than 7 days, with persistent/progressive cytopenias, raised ferritin, and organomegaly suggested the possibility of HLH in our patients with dengue.

Clinical records of children (<15 years) with serologically confirmed dengue infection admitted at the Institute of Child Health, Kolkata during the Dengue outbreak (July 2012 to November 2012) were reviewed. Out of 358 dengue, 8 developed HLH. The diagnosis of HLH was based on the criteria laid down by the Histiocytic Society in 2004. The clinical and laboratory features are listed in Table I.

TABLE I Clinical and Laboratory Features in the Study Children
Clinical Parameters No. (%) Laboratory Parameters No. (%) Range
Fever  >7 d 8 (100%) Anemia (<9 g/dL) 7 (88%) 6.7-9.2
Rash/mucositis 5 (63%) Thrombocytopenia (<100000/cmm) 8 (100%) 8.8-9.6
Hepatomegaly 8 (100%) Neutropenia (ANC<1000) 6 (75%) 352-1622
Splenomegaly 7 (88%) Raised CRP (>6 mg/L) 8 (100%) 82-216
Bleeding manifestations 6 (75%) Raised SGPT (>50IU/L) 7 (88%) 42-288
Lymphadenopathy 2 (25%) Raised Ferritin (>500 ng/L) 8 (100%) 1832-64,600
Edema 8 (100%) Raised LDH (>500U/L) 8 (100%) 872-2680
Ascites 8 (100%) Raised d-dimer (>1000) 8 (100%) 6800->10,000
Pleural effusion 8 (100%) Raised triglyceride (>265 mg/dL) 7 (88%) 242-638
ARDS 2 (25%) Decreased fibrinogen (<1.5 g/dL) 5 (63%) 86-220
Myocarditis 4 (50%) Altered PT/APTT 8 (100%)
Hypotension 6 (75%) Hemophagocytes in bone marrow 6 (75%)
Encephalopathy 2 (25%)      
Joint pain 2 (25%)      

The children were given supportive therapy in form of blood component transfusions, as and when required, along with broad spectrum antibiotics. Definitive therapy was administered in the form of parenteral steroids (dexamethasone 10 mg/m2 in 3-4 divided doses/day) and continued till child was hemodynamically stable or accepting oral feeds. It was switched to oral dexamethasone in a in a tapering dose for 21 d (5 mg/m2 for next 7 days and then 2.5 mg/m2 for further 7 days, and ultimately tapered off over the next 7 days). In seven children, fever subsided within 48-72 h of starting steroids; reversal of cytopenias and regression of hepato-splenomegaly occurred over the next 4-7 days. Serum ferritin started normalizing within a week. Intravenous immunoglobulin was used (1 g/kg) in one patient as a rescue measure as the child did not show any significant improvement after 48 hours of starting steroids.

HLH is a potentially life-threatening condition with protean clinical manifestations [2]. HLH secondary to infections (IAHLH) is the commonest, especially in tropical countries. Any infection (virus, bacteria, fungi, protozoa) can give rise to HLH. In the study by Ramachandran, et al. [3], dengue was found to be the leading organism accounting for 5 among 43 cases of HLH. Veerakul, et al. [4] also reported a series of 52 pediatric patients with HLH; 15 were infection associated out of which 3 were caused by dengue. Tan, et al. [5] also reported a comprehensive report of six cases of dengue associated HLH in adults. In our series, we had 8 cases of dengue associated HLH among 358 admitted dengue patients over a time period of 5 months.

Persistence of fever beyond 7-8 days is unusual in dengue and if it persists, secondary sepsis or dengue associated HLH should be kept in mind. In our series, all 8 children presented with fever of more than 7 days along with persistent or progressive cytopenias, unusual organomegaly with clinical deterioration and sterile cultures.

Early identification and treatment with dexamethasone, even a short course of 4 weeks, can give rise to a good outcome.

Contributors: The study was conceptualized by PP and PPG; both were also involved in patient management. All authors were involved in drafting the manuscript.

Funding: None; Competing interests: None stated.

References

1. Loy T, Alberto AD, Perry MC. Familial erythrophagocytic lymphohistiocytosis. Semin Oncol. 1991;18:34-9.

2. Janka G, Elinder G, Imashuku S, Schneider M, Henter J. Infection- and malignancy-associated hemophagocytic syndromes: secondary hemophagocytic lymphohistio-cytosis. Hematol Oncol Clin North Am. 1998;12:435-44.

3. Ramachandran B, Balasubramanian S, Abhishek N, Ravikumar KG, Ramanan AV. Profile of hemophagocytic lymphohistiocytosis in children in a tertiary care hospital in India. Indian Pediatr. 2011;48:31-5.

4. Veerakul G, Sanpakit K, Tanphaichitr VS, Mahasandana C, Jirarattanasopa N. Secondary hemophagocytic lympho-histiocytosis in children: an analysis of etiology and outcome. J Med Assoc Thai. 2002;85:S530-41.

5. Tan LH, Lum LCS, Omar SFS, Kan FK. Hemo-phagocytosis in dengue: Comprehensive report of six cases. J Clin Virol. 2012;55:79-82.

 

Copyright © 1999-2014 Indian Pediatrics